NPPB and hydrops fetalis: This resulted in 37.4% of patients in the HFrEF group having a positive response to HF therapy, including a reduction in LVEDV and LVESV, an increase in LVEF, and the control of circulating NT-proBNP (<2000 pmol/mL).